Clover Health Investments (CLOV) Analyst Estimates Annual - Discounting Cash Flows
Clover Health Investments, Corp.
CLOV (NASDAQ)

* (except for per share items) of USD
Period Ending: 2028
12-31
2027
12-31
2026
12-31
2025
12-31
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
Number of Analysts 1 2 4 3 2 2 1 1 1
Estimated Revenue
Low 2,119 1,892 1,877 1,552 1,348 1,950 3,310 1,447 672
Average 2,171 1,969 1,877 1,589 1,381 1,997 3,367 1,450 674
High 2,253 2,046 1,877 1,650 1,434 2,074 3,461 1,453 675
Estimated EBITDA
Low -496 -450 -413 -363 -315 -605 -508 -337 -157
Average -477 -433 -413 -350 -304 -504 -423 -336 -156
High -466 -416 -413 -341 -297 -403 -339 -335 -156
Estimated EBIT
Low -498 -452 -415 -364 -317 -971 -803 -338 -157
Average -479 -435 -415 -351 -305 -809 -669 -337 -157
High -468 -418 -415 -343 -298 -647 -535 -337 -156
Estimated Net Income
Low 79.4 46.7 -72.3 -69.9 -60.0 -256 -514 -557 -622
Average 82.0 48.7 -30.4 -67.2 -57.7 -213 -428 -556 -620
High 86.0 50.6 24.1 -64.6 -55.4 -171 -342 -554 -619
Estimated SGA Expenses
Low 573 511 507 419 365 508 436 391 182
Average 587 532 507 430 373 635 545 392 182
High 609 553 507 446 388 762 654 393 183
Estimated EPS
Low 0.165 0.097 -0.150 -0.145 -0.124 -0.436 -0.758 -1.155 -1.290
Average 0.170 0.100 -0.067 -0.138 -0.119 -0.416 -0.732 -1.153 -1.287
High 0.178 0.105 0.050 -0.134 -0.115 -0.403 -0.716 -1.150 -1.283
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us